MedPath

Effectiveness of Sambucus Ebulus leaf extract ointment in treatment results of Cutaneous Leishmaniasis

Phase 3
Recruiting
Conditions
Cutaneous Leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT20151012024490N2
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
110
Inclusion Criteria

All patients with confirmed cutaneous leishmaniasis diagnosis

Exclusion Criteria

pregnant women
patients with allergy to antimuan
passing more than three months from the first existence of skin lesions
getting any treatment for leishmaniasis in recent month
patients whose wounds are on the eyelids, ear, nose or near the end of the lips and eyes (less than one centimeter)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ongest diameter of ulceration area. Timepoint: At the first, 7th, 14th, 21th, 28th day of the treatment. And at 28th day after last treatment intervention, if the wound doesn't heal within first 4 weeks. Method of measurement: ruler.;Longest diameter of Induration area. Timepoint: At the first, 7th, 14th, 21th, 28th day of the treatment. And at 28th day after last treatment intervention, if the wound doesn't heal within first 4 weeks. Method of measurement: ruler.;Healing rate. Timepoint: At the first, 7th, 14th, 21th, 28th day of the treatment. And at 28th day after last treatment intervention, if the wound doesn't heal within first 4 weeks. Method of measurement: observation & calculation.;Treatment result. Timepoint: During treatment or during 4 weeks after treatment. Method of measurement: observation & calculation.;Healing rate. Timepoint: During treatment or during 4 weeks after treatment. Method of measurement: observation & calculation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath